ArticleMetabolites2021

Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study.

Patricia Muñoz Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.